RxDoctor Payments Data

Jennifer Williams, MD

Family Medicine · Springboro, OHNPI 1063452654

Payments from drug & device makers

$9,582in general payments, 2019–2025

Across 594 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$1K
  • AbbVie$978
  • Lilly USA, LLC$673
  • Pfizer$627
  • Astellas Pharma US Inc$587
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$9,29197%
  • Education$2913%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,582 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$17,607
Medicare patients
39
Services billed
234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$36,922
MyrbetriqMirabegron30$18,056
MounjaroTirzepatide16$16,813
FarxigaDapagliflozin Propanediol16$12,387
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$7,933
Fosfomycin Tromethamine17$4,645
Janumet XrSitagliptin Phos/Metformin Hcl11$3,093
SymbicortBudesonide/Formoterol Fumarate11$2,528
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$2,019
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$1,489
SynthroidLevothyroxine Sodium22$1,175
Comfort Ez Pen NeedlePen Needle, Diabetic11$1,164
Albuterol Sulfate HfaAlbuterol Sulfate38$811
Levothyroxine Sodium91$735
Pantoprazole Sodium37$612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,240$36,92232 claims
Astellas Pharma US IncMyrbetriq$587$18,05630 claims
Lilly USA, LLCMounjaro$673$16,81316 claims
AstraZenecaFarxiga, Symbicort$1,491$14,91527 claims
MerckJanumet Xr$174$3,09311 claims
AbbVieSynthroid$978$1,17522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Springboro

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →